This randomized controlled experimental study was conducted to determine the effect of self-care-supported motivational interview in patients receiving hemodialysis treatment on self-care and disease adaptation. The research was conducted between October 2020 and March 2021 in the Hemodialysis Unit of a state hospital in a province in the east of Turkey. The universe of the study was 97 patients receiving hemodialysis treatment. The sample size of the research “G. Power-3.1.9.2 ”program was calculated by determining 80%power in size of 0.70 effect. It was understood that a minimum of 68 subjects in total should be included in the research (29). In the first stage, a total of 85 patients who refused to participate in the research and 85 patients who did not comply with the inclusion criteria were included in the analysis. However, the research was completed with a total of 77 patients, 40 and 37 control groups (Fig. 1). Patients were divided into experimental and control groups using simple random sampling method. In order to prevent inter-patient interaction, randomization was performed between hemodialysis sessions of experimental and control groups.
The criteria of the inclusion in the study were as follows: being 18 years and older, having received (HD) treatment for at least three months and longer, getting (HD) treatment for 2 or 3 days a week, not having communicative and mental problems, being literate, not having received (MI) training before, and being volunteer to participate in the study. Patients who did not want to continue were excluded during the study.
Instruments
Personal Information Form (Personal Information Form)
This form, created by the researcher by reviewing the literature, consists of 23 questions in total.
Self-Care Agency Scale (ESCA)
Self-Care Agency Scale was developed by Kearney and Fleischer in 1979. The validity and reliability study of the Turkish version of the scale was conducted in 1993 by Nahcıvan. It consists of 35 items. Each expression of the 5-point Likert type is scored from 0 to 4. The scoring on the scale is as follows: 4: “Defining me a lot”, 3: “Defining me a little”, 2: “No idea”, 1: “Defining me very much”, 0: “He doesn't define me at all”. There are 8 reverse expressions (3, 5, 7, 11, 17, 20, 24, 29) on the scale. The maximum score to be obtained from the scale is 140. Cronbach’s alpha coefficient of the scale was determined as 0.89. The increase in points from the scale indicates that the self-care agency of the patients increased (21). This research found the Cronbach’s Alfa internal consistency coefficient of the scale as 0.910
Adaptation to Chronic llness Scale (ACISS)
The scale was developed by Atik and Karatepe in 2016 to measure the level of compliance of individuals with chronic disease. The scoring is made as follows: 1: I never agree, 2: I do not agree, 3: I am indecisive, 4: I agree and 5: I fully agree. The scale has 5 -point Likert type and three sub -dimensions (physical adaptation, social adaptation and psychological adaptation).
The items 1, 9, 10, 13, 14, 15, 16, 18, 22, 23, 24 measure physical adaptation (Max = 55, Min = 11 Points ), the items 2, 3, 5, 7, 17, 19, 25 measure social adaptation (max = 35, min = 7 points), and the items 4, 6, 8, 11, 12, 20, 21 measure psychological adaptation in the scale consisting of 25 items in total. Negative items are scored as 1: 5, 2: 4, 3: 3, 4: 2, 5: 1. Article 1, 2, 3, 4, 7, 8, 9, 10, 11, 13, 14, 15, 16, 18, 21, 22, 23 are normally scored whereas items 5, 6, 12, 17, 19, 20, 24, 25 are scored reversely. The high scores obtained from the sub -dimensions and/or all of the scale mean that patients' adaptation levels are also high. The Cronbach Alpha internal consistency coefficient of the scale was found to be 0.88 (29). This research found the Cronbach’s Alfa internal consistency coefficient of the scale as 0.748.
Randomization
Patients receiving hemodialysis treatment in the hemodialysis unit of the hospital were divided into two different groups. The first group of patients receive hemodialysis treatment on Monday, Wednesday, and Friday, the second group of patients on Tuesday, Thursday, and Saturdays. Hemodialysis unit has two sessions on Monday, Wednesday, and Friday two sessions (one session morning, other sessions in the afternoon), Tuesday, Thursday, and Saturday two sessions (one session morning, other session afternoon). Four sessions in the hemodialysis unit were listed. Four lots were drawn by a person who was not aware of the study and groups were formed. Respectively, the first lot of experiment, the second draw control, the third draw experiment and the fourth lot control group was made. Thus, the patients during Monday, Wednesday, and Friday morning and afternoon sessions, Tuesday, Thursday, and Saturday morning and afternoon patients in the patients formed the experimental group.
Data Collection
The data were collected through face to face and individual interviews with patients. At the beginning of the study (pre-test), personal information form, (ESCA) and (ACISS) were applied to patients in both groups. Each patient allocated approximately 15–20 minutes.
Experimental Group
After the pre-test data were collected, the patients in the experimental group were informed about the self-care-supported motivational interview sessions. Following the collection of the first data, motivational interview sessions with patients started in the second week. The sessions took place during the hemodialysis session. A total of 6 sessions were held, including a session once a week. Self-care training was given in the first, second and third sessions. In the fourth, fifth and sixth sessions, a motivational interview was held. All sessions were performed individually with patients and each session lasted about 15–20 minutes (Table 1).
Table 1
self-care supported motivational interview program content
Session | Technique | Content | Method |
First Session (First Week) | Self-care training | Hand Hygiene Mouth, Dental and Prosthesis Care Leather, hair, foot and nail care | Face-to-face once a week 15–20 min |
Second Session (Second Week) | Self-care training | Toilet habits and cleaning Sleep and rest | Face-to-face once a week 15–20 min |
Third Session (Third Week) | Self-care training | Compliance with treatment sessions Compliance with nutritional diet Compliance with the liquid diet Use of salt | Face-to-face once a week 15–20 min |
Fourth, fifth and sixth Session (Fourth, fifth and sixth Week) | Motivational Interview | Creation of the Agenda Release of Ambivalences Use of Decision Balance Importance and consumption test implementation Plan for change Strengthening of change commitment | Face-to-face once a week 15–20 min |
6 weeks after the collection of pre-test data (seventh week) (ESCA) and (ACISS) were applied for the second time (pos-test). One (1) months after the Post-test data was collected, (ESCA) and (ACISS) were repeated for the third time (follow-up test).
Control Group
After the pre-test data were collected in the control group, the patients continued their routine treatment and no motivational interview (MI) was conducted with this group. After 6 weeks (seventh week), (ESCA) and (ACISS) were applied to this group for the second time (post-test). One month after the post-test data was collected, (ESCA) and (ACISS) were repeated for the third time (follow-up test).
Self-Care and Disease Adaptation Training Guide
This guide prepared for patients receiving hemodialysis treatment and aimed at developing self-care activities and adapt to the disease was developed in the light of the relevant literature collected by researchers (12, 15, 19, 23, 28, 30, 31). The opinions of the five experts were used in the development of the guide. Self-care and disease adaptation training guide was given to the experimental group after the first session of the (MI) and the control group at the end of the study. In addition, the sound and video recording of the self-care and adaptation training guide was sent to the phones of patients or relatives.
Ethical Consideration
Before starting the research, written permissions were obtained from the Ethics Committee and the institution where the study will be carried out. Clinical Trials number received. (ClinicalTrials.gov Identifier: NCT053984329. Patients were informed about the study before the data was collected and then the approval of each participant. The principle of ‘protection of privacy and confidentiality’ was adhered to by notifying the patients that the information obtained will be kept confidential. The inclusion of those who want to participate in the study voluntarily shows that it was adhered to the principle of ‘respect for autonomy’. In general, the principles of ‘not harming/ benefits’ to the participants were adhered to.
Data Analysis
The data were analyzed in SPSS 22 package program (SPSS Inc., Chicago, IL, USA). The distribution of the data was tested in terms of normality by Kurtosis and Skewness test. Data descriptive statistics, chi-square analysis, T test in independent groups, Mann Whitney U test, Wilcoxon sequence test and Friedman test were analyzed. Descriptive statistics number (n), percent (%), average ± standard deviation (± SD) were considered. The statistical importance was accepted as p < 0.05.